Since 2001, when our research group proposed for the first time MCM-41 as a drug release
system, the scientific community has demonstrated a growing interest in mesoporous silica …

It is reported that pulmonary fibrosis has become one of the major long-term complications of
COVID-19, even in asymptomatic individuals. Currently, despite the best efforts of the global …

Mesoporous silica nanoparticles have been broadly applied as drug delivery systems owing
to their exquisite features, such as excellent textural properties or biocompatibility. However …

Drug delivery to the lungs by inhalation offers a targeted drug therapy for respiratory
diseases. However, the therapeutic efficacy of inhaled drugs is limited by their rapid …

Encapsulation of cargoes in nanocontainers is widely used in different fields to solve the
problems of their solubility, homogeneity, stability, protection from unwanted chemical and …

Mesoporous silica nanoparticles (MSNs) exhibit the typical characteristics of inorganic
materials that make them promising drug delivery carriers for cancer therapy. Their structural …

Mesoporous silica nanomaterials (MSNs) have made remarkable achievements and are
being thought of by researchers as materials that can be used to effect great change in …

The treatment and management of tuberculosis using conventional drug delivery systems
remain challenging due to the setbacks involved. The lengthy and costly treatment regime …

The ever‐growing interest for finding efficient and reliable methods for treatment of diseases
has set a precedent for the design and synthesis of new functional hybrid materials, namely …

Targeted delivery of anticancer drug specifically to tumor site without damaging normal
tissues has been the dream of all scientists fighting against cancer for decades. Recent …